The senescence-associated secretory phenotype is potentiated by feedforward regulatory mechanisms involving Zscan4 and TAK1-Reference-Cited by-同舟云学术

The senescence-associated secretory phenotype is potentiated by feedforward regulatory mechanisms involving Zscan4 and TAK1

Published:2018-04-30 Issue:1 Volume:9 Page:
ISSN:2041-1723
Container-title:Nature Communications
language:en
Short-container-title:Nat Commun

Author:

Zhang Boyi,Fu Da^ORCID,Xu Qixia,Cong Xianling,Wu Chunyan,Zhong Xiaoming,Ma Yushui,Lv Zhongwei,Chen Fei,Han Liu,Qian Min^ORCID,Chin Y. Eugene,Lam Eric W. -F.^ORCID,Chiao Paul,Sun Yu^ORCID

Publisher

Springer Science and Business Media LLC

Subject

General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry

Link

http://www.nature.com/articles/s41467-018-04010-4.pdf

Reference52 articles.

1. Klemm, F. & Joyce, J. A. Microenvironmental regulation of therapeutic response in cancer. Trends Cell. Biol. 25, 198–213 (2015).

2. Junttila, M. R. & de Sauvage, F. J. Influence of tumour micro-environment heterogeneity on therapeutic response. Nature 501, 346–354 (2013).

3. Holohan, C., Van Schaeybroeck, S., Longley, D. B. & Johnston, P. G. Cancer drug resistance: an evolving paradigm. Nat. Rev. Cancer 13, 714–726 (2013).

4. Lopez, J. S. & Banerji, U. Combine and conquer: challenges for targeted therapy combinations in early phase trials. Nat. Rev. Clin. Oncol. 14, 57–66 (2017).

5. Wei, W. et al. Single-cell phosphoproteomics resolves adaptive signaling dynamics and informs targeted combination therapy in glioblastoma. Cancer Cell. 29, 563–573 (2016).

Cited by 159 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cellular senescence: A novel therapeutic target for central nervous system diseases;Biomedicine & Pharmacotherapy;2024-10

2. Repurposing the plant-derived compound apigenin for senomorphic effect in antiaging pipelines;2024-09-10

3. Senescence-associated secretory phenotype regulation by dual drug delivery biomimetic nanoplatform for enhanced tumor chemotherapy;Molecular Therapy: Oncology;2024-09

4. Safety of low-intensity extracorporeal shock wave therapy in prostate disorders: in vitro and in vivo evidence;Asian Journal of Andrology;2024-08-06

5. Senescence in the bone marrow microenvironment: A driver in development of therapy-related myeloid neoplasms;Journal of Bone Oncology;2024-08